Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older.
- People who have been diagnosed with persistent atrial fibrillation (an ongoing irregular heartbeat).
- People who have an elective cardioversion (a planned procedure to restore a normal heart rhythm) scheduled at the University of Ottawa Heart Institute (UOHI).
- People who are under the care of the heart rhythm specialist team at UOHI.
Who may not be able to join:
- People who are known to have a blood clot in a specific part of the heart called the left atrial appendage.
- People for whom blood-thinning medication is not considered safe or appropriate.
- People who are already taking part in another clinical trial that involves random assignment to treatment groups.
- People who do not meet all of the inclusion criteria listed above.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mehrdad Golian, Ottawa Heart Institute Research Corporation
Phone: 613-696-7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ECV success
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.